Serum Separation Gel Market Projected to Reach $11.96 Billion by 2032, Growing at a CAGR of 5.1%

Market Overview:

The global serum separation gel market size is expected to reach USD 11.96 billion by 2032, exhibiting the CAGR of 5.1% during the forecast period.

For years, blood collection has been an essential constituent of medical research, identification, observation, and treatment. The blood extracted from the body is an important starting point of particulars for medical experts in the context of a patient’s condition, such as their blood chemistry, electrolyte levels, blood cells, and more. But supervising blood samples can be a daunting task, and it needs particular instruments to sanction the probity of samples. Serum separating gels and supplements for blood collection are some of the instruments that help in sorting out blood constituents, sustaining blood clotting, and maintaining sample solidity.

Market Growth Factors

• The serum separation gel industry is anticipated to witness significant prospects due to factors such as a continuous upsurge in detrimental illnesses and growing healthcare disbursement.

• The sizeable upsurge in the aggregate number of blood banks and blood tests globally that examine the condition of the kind of blood and the persistent escalation in the pervasiveness of bloodstream infections involving nosocomial candidemia is one of the prominent factors driving the market growth.

Download Free Sample PDF Copy of the Report:

https://www.polarismarketresearch.com/industry-analysis/serum-separation-gel-market/request-for-sample

Major Participants

The market is reasonably splintered in nature. Prominent firms are engaged in elements such as product standards, productive pricing, superior marketing procedures, and conformity with administrative directives and needs. Some of the main market contenders are:

• BD Biosciences (US)
• Becton, Dickinson and Company (US)
• Corning Incorporated (US)
• FL Medical Srl (Italy)
• Kabe Labortechnik GmbH (Germany)
• Labnet International (US)
• Narang Medical Limited (India)
• Qiagen NV (Netherlands)
• Sarstedt AG & Co. KG (Germany)
• Sekisui Chemical Co. Ltd. (Japan)
• Terumo Corporation (Japan)
• Thermo Fisher Scientific (US)

Geographical Landscape

The regions covered in the report are Europe, North America, Asia Pacific, Middle East & Africa, and Latin America. Also, according to a study in 2023, North America held the largest serum separation gel market share. This is accelerated by an extreme escalation in the cases of hematological illnesses and contagious diseases and the obtainability of an extensive aggregate of blood banks with the modern framework. Moreover, because of advancing healthcare framework and disbursement in advancing nations, the Asia Pacific region is expected to expand at the fastest rate.

Serum Separation Gel Market, Regional Outlook (Revenue – USD Billion, 2019-2032)

• North America
  • Product Type Outlook
    • Serum Separation Gel Integrated with Tube
    • Serum Separation Gel without Tube
  • End User Outlook
    • Hospitals and Clinics
    • Pharmaceutical & Biotechnology Companies
    • Diagnostic Laboratories
    • Others
• Europe
  • Product Type Outlook
    • Serum Separation Gel Integrated with Tube
    • Serum Separation Gel without Tube
  • End User Outlook
    • Hospitals and Clinics
    • Pharmaceutical & Biotechnology Companies
    • Diagnostic Laboratories
    • Others

Recent Developments in the Skincare Industry

• Salve Pharma Launches Ageless Beauty Product Range (April 2023):
  Salve Pharma introduced a new range of products aimed at promoting ageless beauty and boosting confidence. The collection, specially developed to help users regain a youthful appearance and rejuvenate their skin, includes four innovative products:
  • Anti-Aging Serum
  • Honey Locust Skin Gel
  • Pep Se Pure Peptide Serum
  • Pre-Make-Up Primer Cream

The upsurge in the number of blood banks globally, the growing use of serum separation gels in various healthcare settings, including hospitals, clinics, and research & academics, and the growing occurrence of bloodstream infections are prominent factors driving the global market growth. Growing need for accurate and advanced diagnostic testing facilities as a result of the increased prevalence of diseases worldwide, driving the adoption of serum separation gels as they are essential components of several diagnostic assays.